Association between Glycemic Control and Clinic Attendance in Emerging Adults with Type 1 Diabetes: A Tertiary Center Experience

Table 2

Comparison of diabetes-related characteristics of emerging adults with type 1 diabetes during the studied year stratified by the attainment of treatment targets.

HbA1c, % (mmol/mol)	≤7 (53)	>7 (53)
Patients, (%)	74	187
Age at diagnosis, median (IQR), years	13.3 (10.1, 16.3)	11.5 (8.8, 14.4)	0.020
Duration of diabetes, median (IQR), years	11.4 (7.1, 16.1)	11.0 (8.2, 15.3)	0.877
Autoimmune comorbidities, (%)	13 (17.6)	33 (17.6)	1
Current treatment modality, (%)
Multiple daily injections	41 (55.4)	112 (59.9)	0.600
Insulin pump	33 (44.6)	75 (40.1)
Annual number of scheduled visits, median (IQR)	3 (2, 4)	4 (3, 5)	<0.001
Annual number of clinic visits, median (IQR)	2 (2, 3)	3 (2, 3)	0.043
Attendance rate, median (IQR), percentage	100 (67, 100)	75 (50, 100)	0.020
Presence of hypoglycemic events, per 100 patient-years	2.7	1.1	0.333
Presence of diabetic ketoacidosis, per 100 patient-years	1.4	1.1	0.847
Presence of diabetes-related hospitalizations, per 100 patient-years	2.7	2.2	0.789
Microvascular complications, per 100 patient-years	0.83	0.58	0.454

Data are presented as median and interquartile range (IQR) unless otherwise indicated. HbA1c, glycated hemoglobin; , number; %, percentage. was considered significant.